Teva Pharmaceutical Industries Limited (TEVA) Q3 2026 Earnings Call Transcript

Teva Pharmaceutical Industries Limited ( TEVA ) Q3 2026 Earnings Call November 3, 2026 8:00 AM EST Company Participants Christopher Stevo - Senior Vice President of Investor Relations & Competitive Intelligence Richard Francis - President, CEO & Director Eric Hughes - Executive VP of Global R&D and Chief Medical Officer Eliyahu Kalif - Executive VP & CFO Conference Call Participants Umer Raffat - Evercore ISI Institutional Equities, Research Division Douglas Tsao - H.C. Wainwright & Co, LLC, Research Division Glen Santangelo - Barclays Bank PLC, Research Division David Amsellem - Piper...